risankizumab
E1782743
UNEXPLORED
Risankizumab is a humanized monoclonal antibody used to treat moderate to severe plaque psoriasis and other inflammatory conditions by selectively targeting the interleukin-23 (IL-23) pathway.
All labels observed (1)
| Label | Occurrences |
|---|---|
| risankizumab canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.